Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,736,622
-
Share change
-
-7,286,755
-
Total reported value
-
$2,593,000
-
Price per share
-
$0.45
-
Number of holders
-
19
-
Value change
-
-$19,835,577
-
Number of buys
-
7
-
Number of sells
-
21
Institutional Holders of EPIRUS BIOPHARMACEUTICALS IN - COM (EPRSQ) as of Q2 2016
As of 30 Jun 2016,
EPIRUS BIOPHARMACEUTICALS IN - COM (EPRSQ) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,736,622 shares.
The largest 10 holders included
TPG Group Holdings (SBS) Advisors, Inc., Camber Capital Management LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, KCG Holdings, Inc., GEODE CAPITAL MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., TWO SIGMA SECURITIES, LLC, Bank of New York Mellon Corp, and BANK OF AMERICA CORP /DE/.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.